Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02700464
Recruitment Status : Active, not recruiting
First Posted : March 7, 2016
Last Update Posted : September 23, 2019
Sponsor:
Information provided by (Responsible Party):
Nucleix Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : March 2020